| Samuel Fiore, PHARMD | |
|
89 Nh Route 25, Meredith, NH 03253-6314 | |
| (603) 253-5484 | |
| Not Available |
| Full Name | Samuel Fiore |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 89 Nh Route 25, Meredith, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558812115 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | R2764 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Samuel Fiore, PHARMD 89 Nh Route 25, Meredith, NH 03253-6314 Ph: (603) 253-5484 | Samuel Fiore, PHARMD 89 Nh Route 25, Meredith, NH 03253-6314 Ph: (603) 253-5484 |
News Archive
Brain-computer interfaces (BCIs) are an emerging assistive technology, enabling people with paralysis to type on computer screens or manipulate robotic prostheses just by thinking about moving their own bodies.
The University of Colorado at Colorado Springs will work collaboratively with the Texas A&M Health Science Center in the areas of bioenergetics, immunology and cell life, according to a memorandum of understanding between the two schools announced Monday, April 10.
Infants and very young children who are exposed to anesthesia may experience higher rates of learning disabilities and cognitive difficulties than children who are not exposed to anesthesia, according to research and emerging data presented during the SmartTots: Pediatric Anesthesia Neurotoxicity panel at the International Anesthesia Research Society annual meeting in Vancouver, B.C.
While the health effects of breastfeeding are well-recognized and apply to both mothers and children, some mothers may not be able to produce a milk supply to meet the needs of their child.
Keryx Biopharmaceuticals today announced completion of patient enrollment in the long-term study component of its Phase 3 registration program of Zerenex, the Company's ferric iron-based phosphate binder for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with end-stage renal disease (ESRD) on dialysis.
› Verified 2 days ago
Tracy Elizabeth Bourbeau, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 38 Nh Route 25, Meredith, NH 03253 Phone: 603-279-2230 | |
Ms. Carol A Walker, R PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 31 Meredith Bay Dr, Meredith, NH 03253 Phone: 603-279-3037 | |
Hunter Paul Marcoux I, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 50 Nh Route 25 Unit 5, Meredith, NH 03253 Phone: 603-279-2230 | |
Dr. Liam Lombard, PHARM-D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 38 Nh 25 Unit 5, Meredith, NH 03253 Phone: 603-279-2230 | |
Mr. Jay A. Hall, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 38 Nh Route 25, Meredith, NH 03253 Phone: 603-279-4551 | |
Igor Katsenelenbogen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 89 Nh Route 25, Meredith, NH 03253 Phone: 603-279-4551 |